SweetValueLab
Write for us

Regeneron Pharmaceuticals, Inc. — Major Holders & Superinvestors

REGN
NASDAQHealthcareBiotechnologyCIK 0000872589regeneron.comAbout REGN
Last close · Oct 16, 2026790.74−5.60 (−0.70%)
Market cap$81.4B

Of the 85 managers this site tracks, 4 held Regeneron (REGN) at the end of Q2 2026, their latest 13Fs. The largest position by value was Dodge & Cox's, $3.0B; Mason Hawkins's ($95.0M) and Harry Burn's ($79.2M) follow. No Schedule 13D or 13G is on file for REGN from the activists and large holders the site follows.

Superinvestors holding REGN

4 of the tracked managers · latest 13F
ManagerFirmQuarterSharesValue

13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.